Anatomy of T Cell Autoimmunity to Myelin Oligodendrocyte Glycoprotein (MOG): Prime Role of MOG44F in Selection and Control of MOG-reactive T Cells in H-2b Mice
Overview
Authors
Affiliations
Myelin oligodendrocyte glycoprotein (MOG) is an important myelin target antigen, and MOG-induced EAE is now a widely used model for multiple sclerosis. Clonal dissection revealed that MOG-induced EAE in H-2(b) mice is associated with activation of an unexpectedly large number of T cell clones reactive against the encephalitogenic epitope MOG35-55. These clones expressed extremely diverse TCR with no obvious CDR3alpha/CDR3beta motif(s). Despite extensive TCR diversity, the cells required MOG40-48 as their common core epitope and shared MOG44F as their major TCR contact. Fine epitope-specificity analysis with progressively truncated peptides suggested that the extensive TCR heterogeneity is mostly related to differential recognition of multiple overlapping epitopes nested within MOG37-52, each comprised of a MOG40-48 core flanked at the N- and/or the C-terminus by a variable number of residues important for interaction with different TCR. Abrogation of both the encephalitogenic potential of MOG and T cell reactivity against MOG by a single mutation (MOG44F/MOG44A), together with effective down-regulation of MOG-induced EAE by MOG37-44A-52, confirmed in vivo the primary role for MOG44F in the selection/activation of MOG-reactive T cells. We suggest that such a highly focused T cell autoreactivity could be a selective force that offsets the extensive TCR diversity to facilitate a more "centralized control" of pathogenic MOG-related T cell autoimmunity.
Min C, Zhuajin B, Peidong L, Ruoyu L, Ju L, Hongbo L Front Immunol. 2025; 15():1510097.
PMID: 39845958 PMC: 11753215. DOI: 10.3389/fimmu.2024.1510097.
Lack of the MHC class II chaperone H2-O causes susceptibility to autoimmune diseases.
Welsh R, Song N, Foss C, Boronina T, Cole R, Sadegh-Nasseri S PLoS Biol. 2020; 18(2):e3000590.
PMID: 32069316 PMC: 7028248. DOI: 10.1371/journal.pbio.3000590.
Blanchfield L, Sabatino Jr J, Lawrence L, Evavold B J Immunol. 2017; 199(8):2680-2691.
PMID: 28887429 PMC: 5768416. DOI: 10.4049/jimmunol.1700792.
Yannakakis M, Simal C, Tzoupis H, Rodi M, Dargahi N, Prakash M Int J Mol Sci. 2017; 18(6).
PMID: 28594344 PMC: 5486038. DOI: 10.3390/ijms18061215.
Kaushansky N, Eisenstein M, Boura-Halfon S, Hansen B, Nielsen C, Milo R J Biol Chem. 2015; 290(24):15260-78.
PMID: 25911099 PMC: 4463466. DOI: 10.1074/jbc.M115.641209.